Michael Rich

发表

Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases.

Sonya S. Shin, J. Mukherjee, P. Farmer, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical Outcomes of a Comprehensive Integrated Program for HIV-Exposed Infants: A 3-Year Experience Promoting HIV-Free Survival in Rural Rwanda

M. Franke, P. Mugwaneza, N. Gupta, 2013, Journal of acquired immune deficiency syndromes.

Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis

J. Furin, Michael Rich, G. Brigden, 2016, Emerging infectious diseases.

Hypokalemia among patients receiving treatment for multidrug-resistant tuberculosis.

Sonya S. Shin, J. Furin, Michael Rich, 2004, Chest.

Round Table Controlling multidrug-resistant tuberculosis and access to expensive drugs : a rational framework

E. Nardell, J. Mukherjee, J. Bayona, 2002 .

In Madagascar, Use Of Health Care Services Increased When Fees Were Removed: Lessons For Universal Health Coverage.

P. Farmer, M. Murray, M. Bonds, 2017, Health affairs.

Improving Prevention of Mother-to-Child Transmission of HIV Care and Related Services in Eastern Rwanda

P. Farmer, A. Binagwaho, Jim Y. Kim, 2010, PLoS medicine.

Comprehensive and integrated district health systems strengthening: the Rwanda Population Health Implementation and Training (PHIT) Partnership

Chunling Lu, Fidele Ngabo, Lisa R Hirschhorn, 2013, BMC Health Services Research.

Culture conversion at six months in patients receiving delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis.

Ye Yint Naing., L. Lecca, M. Franke, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Geographic barriers to establishing a successful hospital referral system in rural Madagascar

V. Herbreteau, M. Bonds, F. Ihantamalala, 2021, BMJ Global Health.

Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience.

P. Farmer, M. Becerra, S. Keshavjee, 2012, Bulletin of the World Health Organization.

Catching up to a fast-moving target: Evaluation of a health system strengthening intervention in rural Rwanda 2005-2010 using data from repeated cross-sectional surveys

Didi Bertrand Farmer, P. Farmer, A. Binagwaho, 2017, bioRxiv.

Bedaquiline overdose: A case report.

Michael Rich, L. Molfino, Oleksandr Telnov, 2019, International Journal of Infectious Diseases.

Principles for designing future regimens for multidrug-resistant tuberculosis.

C. Horsburgh, P. Phillips, H. McIlleron, 2014, Bulletin of the World Health Organization.

710: A CASE OF LATE-ONSET PAZOPANIB-INDUCED POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME

Michael Rich, Adarsh Sidda, R. Dasgupta, 2019 .

Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective

M. Franke, S. Vilbrun, C. R. Horsburgh, 2023, PLOS global public health.

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens

M. Franke, K. Seung, A. Khan, 2019, BMC Infectious Diseases.

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

H S F Fraser, H. Fraser, L. Thorpe, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru.

J. Mukherjee, P. Farmer, S. Shin, 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study

Sonya S. Shin, E. Nardell, J. Mukherjee, 2008 .

Retreatment management strategies when first-line tuberculosis therapy fails.

J. Bayona, M. Becerra, S. C. Appleton, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

Richard G. White, T. Holtz, J. Bayona, 2011, European Respiratory Journal.

Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-up

M. Franke, Stephanie Law, S. Vilbrun, 2023, medRxiv.

Principles for designing future regimens for multidrug-resistant tuberculosis.

H. McIlleron, E. Nuermberger, M. Balasegaram, 2014, Bulletin of the World Health Organization.

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study

Sonya S. Shin, E. Nardell, J. Mukherjee, 2008, The Lancet.

Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia.

Sonya S. Shin, J. Mukherjee, P. Farmer, 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience.

Sonya S. Shin, P. Farmer, M. Becerra, 2012, Bulletin of the World Health Organization.

Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects.

T. Tupasi, J. Bayona, V. Leimane, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.